University of Kentucky Gill Heart Institute is a clinical research site located in Lexington, Kentucky, United States 40536.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Kentucky Gill Heart Institute has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Ischemic Heart Failure, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Myocardial Infarction.
Sponsors: Juventas Therapeutics, Inc., Intellia Therapeutics, University of California, San Francisco.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Kentucky Gill Heart Institute has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Kentucky Gill Heart Institute has 4 clinical trials on record, with 1 currently active. Their work covers Ischemic Heart Failure, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Myocardial Infarction.
Yes — University of Kentucky Gill Heart Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.